The effect of coenzyme Q10 therapy in Parkinson disease could be symptomatic.
Horstink
Martin W I M
MW
van Engelen
Baziel G
BG
D000368:Aged; D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage / Q000032:analysis / Q000627:therapeutic use*; D003067:Coenzymes; D018450:Disease Progression; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D006801:Humans; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy* / Q000209:etiology*; D051381:Rats; D016896:Treatment Outcome; D014451:Ubiquinone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood / Q000627:therapeutic use*; D014810:Vitamin E / Q000494:pharmacology
D000975:Antioxidants; D003067:Coenzymes; D014451:Ubiquinone; D014810:Vitamin E; C024989:coenzyme Q10